Earnings History Data for Seelos Therapeutics, Inc. (SEEL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Seelos Therapeutics, Inc.

Seelos Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focused on the development and advancement of novel therapeutics to address unmet medical needs for central nervous system disorders. The company's product pipeline consists of SLS-002, SLS-006, SLS-008, SLS-010 and SLS-012 which are in clinical stage. Seelos Therapeutics Inc., formerly known as Apricus Biosciences Inc., is based in New York, United States.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
15-05-2023	PM	SEEL	Seelos Therapeutics, Inc.	103.54	-0.12	0.00	-0.13	Seelos Therapeutics GAAP EPS of -$0.12 misses by $0.02, revenue of $0.81M [5/15/2023 9:25 AM]	0.91	0.0 (0.13%)	0.87	-0.04 (-3.98%)	0.55 - 1.52	146,423	360,000	891
Seelos Therapeutics GAAP EPS of -$0.12 misses by $0.02, revenue of $0.81M [5/15/2023 9:25 AM]
09-08-2021	PM	SEEL	Seelos Therapeutics, Inc.	169.00	-0.08	-0.17	0.00		2.20	0.04 (1.61%)	2.17	0.0 (0.00%)	0.56 - 6.60	1,256,761	1,530,000	8,462
Seelos Therapeutics Announces Mid-Year 2021 Business and Clinical Update [Aug-09-21 08:00AM] Companies Like Seelos Therapeutics (NASDAQ:SEEL) Are In A Position To Invest In Growth [Aug-09-21 10:47AM]